NCT04568798 is a NA clinical trial of Sana Sham Device in Fibromyalgia, sponsored by Sana Health.

Who is sponsoring NCT04568798?

NCT04568798 is sponsored by Sana Health.

What drugs are being tested in NCT04568798?

Interventions in NCT04568798: Sana Sham Device.

What condition does NCT04568798 study?

NCT04568798 studies Fibromyalgia.

Is NCT04568798 still recruiting?

NCT04568798 is currently completed. Last updated 31 March 2022.

Last reviewed 2022-03-31 · How we verify

NCT04568798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Sana Treatment in Fibromyalgia

Completed NA Last updated 31 March 2022

What this trial tests

NA trial testing Sana Sham Device in Fibromyalgia in 166 participants. Completed in 4 March 2022.

Timeline

14 July 2020

Primary endpoint
30 October 2021

4 March 2022

Quick facts

Lead sponsor	Sana Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	166
Start date	14 July 2020
Primary completion	30 October 2021
Estimated completion	4 March 2022
Sites	1 location across United States

Drugs / interventions tested

Sana Sham Device

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Sana Health — full company profile →

Who can join

Adults 18 to 65, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to evaluate the effectiveness of an experimental device called the Sana Pain Reliever Device (Sana Device) on treating pain due to fibromyalgia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other Sana Health trials

Trials by the same sponsor.

NCT05319405 — Effectiveness of Sana Treatment in Post-Traumatic Stress Disorder (PTSD) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04568798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sana Health
Last refreshed: 31 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04568798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing